The expanding demand for controlled immunological research and therapeutic creation has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using multiple expression platforms, including prokaryotic hosts, higher cell populations, an